Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technolo-gies to basic science cancer researchers – to create an environ-ment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imag-ing adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

MIPS collaboration with Chemistry leads to new functional delivery system of mRNA

February 16, 2017

  • Research Leads to Assay that May Help Screen Cardiotoxicity of Chemotherapy Drugs

    February 15, 2017…

Dr. Adam de la Zerda Named Chan Zuckerberg Biohub Junior Investigator

February 8, 2017

  • Molecular Imaging Young Investigator (MIYI) Prize Awardees

    January 24, 2017…

  • 10 Years in the making: 1st human reporter gene imaging for cancer immunotherapy!

    January 18, 2017…